Vir Biotechnology Reminds Stockholders of 2021 Annual General Meeting Details

NEXT STORY
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2021 Financial Results
PREV STORY
FibroGen Reports First Quarter 2021 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BioCryst Initiates Phase 1 Clinical Trial of Galidesivir

RESEARCH TRIANGLE PARK, N.C., Jan. 02, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) ...

author_avatar
NASDAQ Market News

Project HOPE and Boeing Team Up to Boost Maternal and Newborn Care in Hungary

MILLWOOD, Va., Sept. 13, 2016 (GLOBE NEWSWIRE) -- Project HOPE and Boeing are teaming ...

author_avatar
NASDAQ Market News

ZIOPHARM Oncology Reports Second Quarter 2017 Financial Results and Provides Update on Recent Activities

BOSTON, July 31, 2017 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company ...

author_avatar
NASDAQ Market News